157 related articles for article (PubMed ID: 2941316)
1. Repeating sequence homologies in the p36 target protein of retroviral protein kinases and lipocortin, the p37 inhibitor of phospholipase A2.
Weber K; Johnsson N
FEBS Lett; 1986 Jul; 203(1):95-8. PubMed ID: 2941316
[TBL] [Abstract][Full Text] [Related]
2. Primary structure of bovine calpactin I heavy chain (p36), a major cellular substrate for retroviral protein-tyrosine kinases: homology with the human phospholipase A2 inhibitor lipocortin.
Kristensen T; Saris CJ; Hunter T; Hicks LJ; Noonan DJ; Glenney JR; Tack BF
Biochemistry; 1986 Aug; 25(16):4497-503. PubMed ID: 2945590
[TBL] [Abstract][Full Text] [Related]
3. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors.
Haigler HT; Schlaepfer DD; Burgess WH
J Biol Chem; 1987 May; 262(14):6921-30. PubMed ID: 3032981
[TBL] [Abstract][Full Text] [Related]
4. The p35/p36 substrates of protein-tyrosine kinases as inhibitors of phospholipase A2.
Brugge JS
Cell; 1986 Jul; 46(2):149-50. PubMed ID: 2941151
[No Abstract] [Full Text] [Related]
5. Inhibition of phospholipase A2 by protein I.
Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM
Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554
[TBL] [Abstract][Full Text] [Related]
6. Purification of three forms of lipocortin from bovine lung.
Khanna NC; Tokuda M; Waisman DM
Cell Calcium; 1987 Jun; 8(3):217-28. PubMed ID: 2955902
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2.
Hayashi H; Owada MK; Sonobe S; Domae K; Yamanouchi T; Kakunaga T; Kitajima Y; Yaoita H
Biochem J; 1990 Aug; 269(3):709-15. PubMed ID: 2143895
[TBL] [Abstract][Full Text] [Related]
8. [Lipocortin--a Ca2+-binding protein which has anti-phospholipase A2 activity].
Tokuda M; Waisman DM; Hatase O
Seikagaku; 1988 Jan; 60(1):26-31. PubMed ID: 2969024
[No Abstract] [Full Text] [Related]
9. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase.
Huang KS; Wallner BP; Mattaliano RJ; Tizard R; Burne C; Frey A; Hession C; McGray P; Sinclair LK; Chow EP
Cell; 1986 Jul; 46(2):191-9. PubMed ID: 3013422
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
Wallner BP; Mattaliano RJ; Hession C; Cate RL; Tizard R; Sinclair LK; Foeller C; Chow EP; Browing JL; Ramachandran KL
Nature; 1986 Mar 6-12; 320(6057):77-81. PubMed ID: 2936963
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH
FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817
[TBL] [Abstract][Full Text] [Related]
12. Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor.
Ahn NG; Teller DC; Bienkowski MJ; McMullen BA; Lipkin EW; de Haën C
J Biol Chem; 1988 Dec; 263(35):18657-63. PubMed ID: 2974032
[TBL] [Abstract][Full Text] [Related]
13. Lipocortin-independent effect of dexamethasone on phospholipase activity in a thymic epithelial cell line.
Piltch A; Sun L; Fava RA; Hayashi J
Biochem J; 1989 Jul; 261(2):395-400. PubMed ID: 2528346
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 and lipocortin effects.
Dennis EA; Davidson FF
Prog Clin Biol Res; 1990; 349():47-54. PubMed ID: 2144646
[No Abstract] [Full Text] [Related]
15. Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
Davidson FF; Dennis EA; Powell M; Glenney JR
J Biol Chem; 1987 Feb; 262(4):1698-705. PubMed ID: 2948959
[TBL] [Abstract][Full Text] [Related]
16. Binding sites for calcium, lipid and p11 on p36, the substrate of retroviral tyrosine-specific protein kinases.
Johnsson N; Vandekerckhove J; Van Damme J; Weber K
FEBS Lett; 1986 Mar; 198(2):361-4. PubMed ID: 2937654
[TBL] [Abstract][Full Text] [Related]
17. Common domain structure of Ca2+ and lipid-binding proteins.
Geisow MJ
FEBS Lett; 1986 Jul; 203(1):99-103. PubMed ID: 2941317
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
[TBL] [Abstract][Full Text] [Related]
19. Calcium-independent phospholipases from guinea pig digestive tract as probes to study the mechanism of lipocortin.
Gassama-Diagne A; Fauvel J; Chap H
J Biol Chem; 1990 Mar; 265(8):4309-14. PubMed ID: 2137821
[TBL] [Abstract][Full Text] [Related]
20. Lipocortin-like anti-phospholipase A2 activity of endonexin.
Fauvel J; Salles JP; Roques V; Chap H; Rochat H; Douste-Blazy L
FEBS Lett; 1987 May; 216(1):45-50. PubMed ID: 2953628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
